These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 11572740)
1. Prevalence, donation practices, and risk assessment of blood donors with hemochromatosis. Sanchez AM; Schreiber GB; Bethel J; McCurdy PR; Glynn SA; Williams AE; Gilcher R; JAMA; 2001 Sep; 286(12):1475-81. PubMed ID: 11572740 [TBL] [Abstract][Full Text] [Related]
2. Estimates of infectious disease risk factors in US blood donors. Retrovirus Epidemiology Donor Study. Williams AE; Thomson RA; Schreiber GB; Watanabe K; Bethel J; Lo A; Kleinman SH; Hollingsworth CG; Nemo GJ JAMA; 1997 Mar; 277(12):967-72. PubMed ID: 9091668 [TBL] [Abstract][Full Text] [Related]
3. Effect of a national disaster on blood supply and safety: the September 11 experience. Glynn SA; Busch MP; Schreiber GB; Murphy EL; Wright DJ; Tu Y; Kleinman SH; JAMA; 2003 May; 289(17):2246-53. PubMed ID: 12734136 [TBL] [Abstract][Full Text] [Related]
4. Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009. Al Shaer L; AbdulRahman M; John TJ; AlHashimi A Transfusion; 2012 Nov; 52(11):2300-9. PubMed ID: 22691239 [TBL] [Abstract][Full Text] [Related]
5. Demographic characteristics, unreported risk behaviors, and the prevalence and incidence of viral infections: a comparison of apheresis and whole-blood donors. The Retrovirus Epidemiology Donor Study. Glynn SA; Schreiber GB; Busch MP; Kleinman SH; Williams AE; Nass CC; Ownby HE; Smith JW Transfusion; 1998 Apr; 38(4):350-8. PubMed ID: 9595017 [TBL] [Abstract][Full Text] [Related]
6. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS). Glynn SA; Kleinman SH; Schreiber GB; Busch MP; Wright DJ; Smith JW; Nass CC; Williams AE JAMA; 2000 Jul; 284(2):229-35. PubMed ID: 10889598 [TBL] [Abstract][Full Text] [Related]
7. Surveillance of risk profiles among new and repeat blood donors with transfusion-transmissible infections from 1995 through 2003 in the Netherlands. Van der Bij AK; Coutinho RA; Van der Poel CL Transfusion; 2006 Oct; 46(10):1729-36. PubMed ID: 17002629 [TBL] [Abstract][Full Text] [Related]
8. Hemochromatosis subjects as allogeneic blood donors: a prospective study. Leitman SF; Browning JN; Yau YY; Mason G; Klein HG; Conry-Cantilena C; Bolan CD Transfusion; 2003 Nov; 43(11):1538-44. PubMed ID: 14617312 [TBL] [Abstract][Full Text] [Related]
11. Severity of iron overload in hemochromatosis: effect of volunteer blood donation before diagnosis. Barton JC; Preston BL; McDonnell SM; Rothenberg BE Transfusion; 2001 Jan; 41(1):123-9. PubMed ID: 11161257 [TBL] [Abstract][Full Text] [Related]
12. Comparison of demographic and donation profiles and transfusion-transmissible disease markers and risk rates in previously transfused and nontransfused blood donors. Wang B; Higgins MJ; Kleinman S; Schreiber GB; Murphy EL; Glynn SA; Wright DJ; Nass CC; Chang D; Busch MP; Transfusion; 2004 Aug; 44(8):1243-51. PubMed ID: 15265131 [TBL] [Abstract][Full Text] [Related]
13. The infectious disease blood safety risk of Australian hemochromatosis donations. Hoad V; Bentley P; Bell B; Pathak P; Chan HT; Keller A Transfusion; 2016 Dec; 56(12):2934-2940. PubMed ID: 27662424 [TBL] [Abstract][Full Text] [Related]
14. Do patient-related blood donors represent a threat to the safety of the blood supply? Pereira A; Sanz C; Tàssies D; Ramírez B Haematologica; 2002 Apr; 87(4):427-33. PubMed ID: 11940488 [TBL] [Abstract][Full Text] [Related]
15. Does prevalence of transfusion-transmissible viral infection reflect corresponding incidence in United States blood donors? Wang B; Schreiber GB; Glynn SA; Kleinman S; Wright DJ; Murphy EL; Busch MP; Transfusion; 2005 Jul; 45(7):1089-96. PubMed ID: 15987352 [TBL] [Abstract][Full Text] [Related]
16. Hemochromatosis patients as voluntary blood donors. Power TE; Adams PC Can J Gastroenterol; 2004 Jun; 18(6):393-6. PubMed ID: 15190395 [TBL] [Abstract][Full Text] [Related]
17. Blood-donor perceptions of health history screening with a computer-assisted self-administered interview. Sanchez AM; Schreiber GB; Glynn SA; Bethel J; Kessler D; Chang D; Zuck TF; Transfusion; 2003 Feb; 43(2):165-72. PubMed ID: 12559011 [TBL] [Abstract][Full Text] [Related]
18. Non-compliance to infectious disease deferral criteria among Hong Kong's blood donors. Lee SS; Cheung EKH; Leung JNS; Lee CK Vox Sang; 2017 Jul; 112(5):425-433. PubMed ID: 28401619 [TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of FDA variance for blood collection from individuals with hereditary hemochromatosis at a 398-bed hospital-based donor center. Gribble DM; Chaffin DJ; Bryant BJ Immunohematology; 2009; 25(4):170-3. PubMed ID: 20406025 [TBL] [Abstract][Full Text] [Related]
20. The persistence of hepatitis C virus transmission risk in China despite serologic screening of blood donations. Wang J; Liu J; Huang Y; Wright DJ; Li J; Zhou Z; He W; Yang T; Yao F; Zhu X; Wen G; Bi X; Tiemuer MH; Wen X; Huang M; Cao R; Yun Z; Lü Y; Ma H; Guo N; Yu Q; Ness P; Shan H; Transfusion; 2013 Oct; 53(10 Pt 2):2489-97. PubMed ID: 23781978 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]